Stock Screener App

Frei -

Installieren

559.51

0.46% 2.58

Idexx Laboratories Inc (IDXX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt IDXX? Forum Prognose Aktiensplit

Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten

IDEXX Laboratories stock holds high valuation as earnings outlook firms - Ad-hoc-news.de

Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now? - TradingView

IDEXX launches first dual-species point-of-care NT-proBNP test for cardiac disease in cats and dogs - DVM360

IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding - Yahoo Finance

Flossbach Von Storch SE Invests $9.09 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Danske Bank A S Buys New Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Resilient IDEXX Laboratories stock trades in the mid-$550s as investors weigh premium valuation and - Ad-hoc-news.de

Will In-Clinic Cardiac Testing Expansion via Catalyst proBNP Test Change IDEXX Laboratories' (IDXX) Narrative - Sahm

IDXX (IDEXX Laboratories) Cash Flow from Operations : $1,372 Mil (TTM As of Jun. 2026) - GuruFocus

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

IDEXX Laboratories stock holds above the mid-$540s as valuation stays demanding - Ad-hoc-news.de

IDXX (IDEXX Laboratories) Cash From Discontinued Investing Activities : $0 Mil (TTM As of Jun. 2026) - GuruFocus

Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999. - marketscreener.com

Plato Investment Management Ltd Takes $1.48 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution (NASDAQ:IDXX) - Seeking Alpha

IDEXX Laboratories (IDXX) Could Be 22% Undervalued As New Cardiac Test Expands Its Reach - Sahm

Weekly Recap: AI diagnostics expansion and Barclays trims target to $710 - TradingView

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unpacking a 26.86% Potential Upside in the Diagnostics & Research Sector - DirectorsTalk Interviews

IDEXX Laboratories Inc (IDXX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Transamerica Large Core ESG's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

IDEXX Laboratories (IDXX) Institutional Ownership 2026 - MarketBeat

IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch

IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests - MarketBeat

BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $665 - Moomoo

IDEXX Laboratories, Inc. (IDXX) Analyst/Investor DaySlideshow (NASDAQ:IDXX) 2026-08-14 - Seeking Alpha

Handelsbanken Fonder AB Grows Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance Singapore

IDEXX Laboratories Inc (IDXX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance

IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

IDXX|IDEXX Laboratories Inc|Price:569.852|Chg%:-0.728 - TradingKey

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment - marketscreener.com

IDEXX launches in-clinic cardiac test for cats and dogs - Investing.com

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test - Eagle-Tribune

Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating - marketscreener.com

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

NewEdge Advisors LLC Acquires 5,761 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat

Seilern Investment Management Ltd Purchases 16,729 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat

IDEXX Laboratories Inc Stock Historical Valuations | HAM:IX1 - GuruFocus

IDEXX Laboratories Inc Stock Baskets - GuruFocus

IDEXX Laboratories Inc (HAM:IX1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

IDEXX Laboratories Inc (HAM:IX1) Stock Price & 30 Year Financial Data - GuruFocus

IDEXX Laboratories (HAM:IX1) Other Operating Expense : €0 Mil (TTM As of Jun. 2026) - GuruFocus

IDEXX Laboratories (HAM:IX1) Marketable Securities : €0 Mil (As of Jun. 2026) - GuruFocus

IDEXX Laboratories Inc (HAM:IX1) Competitors 2026 - GuruFocus

IDEXX Laboratories Inc Stock Operating Data - GuruFocus

IDEXX Laboratories Inc (HAM:IX1) Stock News, Headlines & Updates - GuruFocus

Who's Buying or Selling IDEXX Laboratories Inc (HAM:IX1) Stock Today? - GuruFocus

IDEXX Labs posts 9% organic growth, raises EPS forecast, driven by global diagnostic expansion. - Pluang

IDEXX Laboratories: Worth The Premium (NASDAQ:IDXX) - Seeking Alpha

IDEXX Laboratories, Inc. $IDXX Shares Sold by Beacon Investment Advisory Services Inc. - MarketBeat

Assenagon Asset Management S.A. Boosts Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Aurora Investment Managers LLC. Makes New Investment in IDEXX Laboratories, Inc. $IDXX - MarketBeat

What Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Indicate? - Moomoo

Janus Henderson Group PLC Cuts Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Clinical Visits Keep Falling. IDEXX Laboratories’ Q2 Earnings Report Say That Doesn’t Matter. - TIKR.com

IDEXX Laboratories, Inc. $IDXX Shares Sold by Empowered Funds LLC - MarketBeat

IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat

IDEXX Labs Is Maintained at Neutral by UBS - Moomoo

IDEXX Labs Is Maintained at Neutral by Citigroup - Moomoo

Jefferies Adjusts Price Target on IDEXX Laboratories to $795 From $792 - Moomoo

UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670 - Moomoo

Citi Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670 - Moomoo

IDEXX Laboratories Inc (HAM:IX1) Stock Earnings Transcripts - GuruFocus

IDEXX Laboratories Inc (IDXX) Stock Up 3.6% and Still Undervalued -- GF Score: 96/100 - GuruFocus

IDEXX Laboratories, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

A

$153.43

3.50%

IQV

$260.24

0.16%

NTRA

$327.72

1.30%

WAT

$410.75

0.01%

ILMN

$223.22

1.74%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters